Luminex Aries M1 System Model: Aries M6V1 Aries Software v1.0 For In Vitro Diagnostic Use i...
FDA Device Recall #Z-2292-2019 — Class II — June 29, 2018
Recall Summary
| Recall Number | Z-2292-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 29, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Luminex Corporation |
| Location | Austin, TX |
| Product Type | Devices |
| Quantity | 153 (140 U.S. and 13 O.U.S.) |
Product Description
Luminex Aries M1 System Model: Aries M6V1 Aries Software v1.0 For In Vitro Diagnostic Use in clinical laboratories. Scanner Label/Labeling: JADAK JDK-2330 REV B 170512-017
Reason for Recall
An incorrect control board and firmware installed in some of the Hand Held Barcode Scanners could result in sample/patient mismatch or duplicate results (from other patients specimens) for a patient order.
Distribution Pattern
Worldwide distribution. US nationwide, Canada, Ireland, Netherlands, Singapore, Thailand, and United Kingdom
Lot / Code Information
ARIES System UDI: 00840487101537 ARIES M1 System UDI: 00840487100080 ARIES-M12V1-IVD, ARIES System ARIES-M6V1-IVD, ARIES M1 System CN-0321-01, ARIES System Handheld Barcode Scanner All scanners manufactured after April 2017 and including Part Number JDK-2330 Rev B.
Other Recalls from Luminex Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1903-2025 | Class II | VERIGENE Gram Negative Blood Culture (BC-GN) Nu... | Apr 16, 2025 |
| Z-2533-2024 | Class II | Verigene Gram Positive Blood Culture (BC-GP) Nu... | Jun 20, 2024 |
| Z-0500-2024 | Class II | Luminex VERIGENE BC-GP Utility Tray (5-Pack Car... | Nov 7, 2023 |
| Z-2023-2023 | Class II | Verigene Enteric Pathogens Nucleic Acid Test (E... | Jun 5, 2023 |
| Z-2024-2023 | Class II | VERIGENE Clostridium difficile Nucleic Acid Tes... | Jun 5, 2023 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.